| Daniel G Malone, MD | |
|
705 S University Ave, Ste 150, Beaver Dam, WI 53916-3053 | |
| (920) 885-2663 | |
| (920) 885-2466 |
| Full Name | Daniel G Malone |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 48 Years |
| Location | 705 S University Ave, Beaver Dam, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346216371 | NPI | - | NPPES |
| 30821700 | Medicaid | WI | |
| 1002676 | Other | WI | PHYSICIANS PLUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 28394 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Community Hospital | Columbus, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prairie Ridge Health Inc | 6800791484 | 41 |
News Archive
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.
Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.
To build on a groundbreaking study that used brain imaging to identify individuals with suicidal thoughts, Carnegie Mellon University's Marcel Just and the University of Pittsburgh's David A. Brent have received a five-year, $3.8 million grant from the National Institute for Mental Health.
Covering the uninsured - a leading principle of health care reform - depends on the critical issue of who gets subsidies to pay for health insurance coverage and when.
On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.
› Verified 3 days ago
| Entity Name | Prairie Ridge Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154403657 PECOS PAC ID: 6800791484 Enrollment ID: O20040210000777 |
News Archive
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.
Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.
To build on a groundbreaking study that used brain imaging to identify individuals with suicidal thoughts, Carnegie Mellon University's Marcel Just and the University of Pittsburgh's David A. Brent have received a five-year, $3.8 million grant from the National Institute for Mental Health.
Covering the uninsured - a leading principle of health care reform - depends on the critical issue of who gets subsidies to pay for health insurance coverage and when.
On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.
› Verified 3 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.
Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.
To build on a groundbreaking study that used brain imaging to identify individuals with suicidal thoughts, Carnegie Mellon University's Marcel Just and the University of Pittsburgh's David A. Brent have received a five-year, $3.8 million grant from the National Institute for Mental Health.
Covering the uninsured - a leading principle of health care reform - depends on the critical issue of who gets subsidies to pay for health insurance coverage and when.
On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel G Malone, MD 1515 Park Ave, Columbus, WI 53925-1618 Ph: (920) 623-2200 | Daniel G Malone, MD 705 S University Ave, Ste 150, Beaver Dam, WI 53916-3053 Ph: (920) 885-2663 |
News Archive
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.
Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.
To build on a groundbreaking study that used brain imaging to identify individuals with suicidal thoughts, Carnegie Mellon University's Marcel Just and the University of Pittsburgh's David A. Brent have received a five-year, $3.8 million grant from the National Institute for Mental Health.
Covering the uninsured - a leading principle of health care reform - depends on the critical issue of who gets subsidies to pay for health insurance coverage and when.
On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.
› Verified 3 days ago
Dr. Harinder Singh Gill, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 707 S University Ave, Beaver Dam, WI 53916 Phone: 920-356-6588 | |
Kenneth L Kuehnl, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 801 S University Ave, Beaver Dam, WI 53916 Phone: 920-885-3369 Fax: 920-885-4752 | |
Mr. George R. Schneider, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 705 S University Ave Ste 510, Beaver Dam, WI 53916 Phone: 920-887-3102 Fax: 920-885-8788 | |
Virginia K Wilson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 705 S University Ave Ste 510, Beaver Dam, WI 53916 Phone: 920-356-9288 Fax: 920-356-1835 | |
Amy J Muchow, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 705 S. University Ave., Beaver Dam, WI 53916 Phone: 920-887-9272 Fax: 920-885-4752 | |
Joel D Miller, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 801 S University Ave, Beaver Dam, WI 53916 Phone: 920-887-9272 Fax: 920-885-4752 |